Diabetic Foot Ulcers Treatment Market Size will Grow at a Lucrative CAGR of 7.5% through 2027

Your avatar
Healtcare
According to a new market report published by Transparency Market Research, the global diabetic foot ulcers treatment market was valued at US$ 5 Bn in 2018 and is estimated to reach a market value of ~US$ 9.6 Bn by 2027, growing at a CAGR of 7.5% from 2019 to 2027. Diabetic foot ulcers are a major complication arising out of diabetes mellitus. Various factors are responsible for this type of chronic wound, such as peripheral neuropathy, and peripheral artery diseases. Chronic wounds have created a significant socioeconomic impact. Chronic wounds generally take longer time to heal and require advanced wound care therapies. Diabetic ulcers are becoming more common due to increased incidence of both type I and maturity-onset diabetes in the developed economies across the world. Thus, increase in prevalence of diabetic foot ulcer is expected to drive the diabetic foot ulcers treatment market in the next few years.
Read Report Overview -   https://www.transparencymarketresearch.com/diabetic-foot-ulcers-treatment-market.html 
The global diabetic foot ulcers treatment market was valued at US$ 5.0 Bn in 2018 and is anticipated to reach US$ 9.6 Bn by 2027, expanding at a CAGR of 7.5% from 2019 to 2027. North America, Europe, and Asia Pacific were major markets for diabetic foot ulcers treatment in 2018. Global diabetic foot ulcers treatment market in Asia Pacific is projected to expand at a high CAGR of 8.0% during the forecast period.
Rise in Prevalence of Chronic Disease to Drive Market
High growth rate of the diabetic foot ulcers treatment market during the forecast period can be attributed to rise in prevalence of chronic diseases such as diabetes, cancer, HIV, and other diseases leading to increased risk of diabetic foot ulcers among the diabetic population; and longer hospital stays due to treatment of these diseases resulting in risk of hospital-acquired pressure ulcers and medical devices-acquired pressure ulcers. A constant increase in geriatric population among developed and developing countries has been observed, along with rise in obesity and peripheral artery diseases, which leads to decreased mobility and increased risk of acquiring chronic ulcers
Request Brochure – 
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=75725 
Wound Care Dressings to be Preferred Treatment Type
In terms of treatment type, the diabetic foot ulcers treatment market has been segmented into wound care dressings, wound care devices, active therapies, and others. The wound care dressings segment is anticipated to hold major share of the market during the forecast period. Increase in incidence of peripheral vascular as well sugar related diseases, and other chronic diseases leading to rising risk of hospital acquired pressure ulcers is expected to drive the segment during the forecast period
Grade 1 Ulcers to Dominate Global Market
In term of grade, the diabetic foot ulcers treatment market has been segmented into grade 1, grade 2, grade 3, grade 4, and grade 5. The grade 1 segment is expected to dominate the market during the forecast period.
Rise in Prevalence of Neuropathic Ulcers to Fuel Market Growth
In terms of type of ulcer, the diabetic foot ulcers treatment market has been segmented into neuropathic ulcers and ischemic ulcers. The neuropathic ulcers segment is expected to dominate the market from 2019 to 2027.
Request COVID Analysis on Diabetic Foot Ulcers Treatment Market – 
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=75725
Hospital Inpatient Settings to be Key End User
In terms of end user, the diabetic foot ulcers treatment market has been categorized into hospital inpatient settings, hospital outpatient settings, community health centers, and home healthcare. In terms of end user, the hospital inpatient settings segment is expected to drive the market. Reasons for growth of the segment include the demand for acute care for the treatment of chronic wounds and rise in incidence of diabetic foot ulcers and pressure ulcers around the world. However, lack of hospital inpatient facilities and availability of limited resources have led to emergence of community health centers and home healthcare facilities for wound care. This is expected to drive community health centers and home healthcare segments during the forecast period.
Request Customization on Diabetic Foot Ulcers Treatment Market Report – 
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=75725
Growth Strategies of Key Players: Diabetic Foot Ulcers Treatment Market
Major players having presence in the global diabetic foot ulcers treatment market include 3M Healthcare, Smith & Nephew Plc., Acelity L.P. Inc., ConvaTec, Inc., Molnlycke Health Care AB, Coloplast A/S, Medtronic Plc, B. Braun Melsungen AG, Organogenesis, Inc., Medline Industries, Inc., and BSN Medical GMBH. These companies engage in research & development activities to develop novel products in order to expand product offerings and customer base
Global Diabetic Foot Ulcers Treatment Market: Segmentation
Diabetic Foot Ulcers Treatment Market, by Treatment Type
Wound Care Dressing
Antimicrobial Dressings
Foam Dressings
Film Dressings
Alginate Dressings
Hydrogel Dressings
Other Dressings
Wound Care Devices
NPWT [Negative Pressure Wound Therapy]
Electromagnetic Devices
HBOT & Electromagnetic Therapy
Active Therapies
Skin Grafts & Substitutes
Growth Factors
Hemostatic Agents & Sealants
Others
Pressure Relief Devices
Traditional Wound Care Products
Others
Diabetic Foot Ulcers Treatment Market, by Grade
Grade 1
Grade 2
Grade 3
Grade 4
Grade 5
Diabetic Foot Ulcers Treatment Market, by Type of Ulcer
Neuropathic Ulcers
Ischemic Ulcers
Diabetic Foot Ulcers Treatment Market, by End User
Hospital Inpatient Settings
Hospital Outpatient Settings
Community Health Centers
Home Health Care
Diabetic Foot Ulcers Treatment Market, by Region
North America
U.S.
Canada
Europe
Germany
France
Italy
U.K.
Spain
Rest of Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Israel
Rest of MEA
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of analysts, researchers, and consultants who use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR Syndicated Research report covers a different sector — such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods, and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.
Contact
TMR
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

Keep discovering on Mamby:

Healthcare
If you liked this post, you may also be interested in...
O
Information Work with us Contact Terms and Conditions FAQs
© 2021, Mamby Investments